90 related articles for article (PubMed ID: 31604003)
21. AICAR and Metformin Exert AMPK-dependent Effects on INS-1E Pancreatic β-cell Apoptosis via Differential Downstream Mechanisms.
Dai YL; Huang SL; Leng Y
Int J Biol Sci; 2015; 11(11):1272-80. PubMed ID: 26435693
[TBL] [Abstract][Full Text] [Related]
22. AMPK activation by AICAR inhibits myogenic differentiation and myostatin expression in cattle.
Miyake M; Takahashi H; Kitagawa E; Watanabe H; Sakurada T; Aso H; Yamaguchi T
Cell Tissue Res; 2012 Aug; 349(2):615-23. PubMed ID: 22622802
[TBL] [Abstract][Full Text] [Related]
23. AICAR-induced activation of AMPK negatively regulates myotube hypertrophy through the HSP72-mediated pathway in C2C12 skeletal muscle cells.
Egawa T; Ohno Y; Goto A; Ikuta A; Suzuki M; Ohira T; Yokoyama S; Sugiura T; Ohira Y; Yoshioka T; Goto K
Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E344-54. PubMed ID: 24347059
[TBL] [Abstract][Full Text] [Related]
24. New synthetic AICAR derivatives with enhanced AMPK and ACC activation.
Scudiero O; Nigro E; Monaco ML; Oliviero G; Polito R; Borbone N; D'Errico S; Mayol L; Daniele A; Piccialli G
J Enzyme Inhib Med Chem; 2016 Oct; 31(5):748-53. PubMed ID: 26446934
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of glucocorticoid-induced apoptosis with 5-aminoimidazole-4-carboxamide ribonucleoside, a cell-permeable activator of AMP-activated protein kinase.
Stefanelli C; Stanic I; Bonavita F; Flamigni F; Pignatti C; Guarnieri C; Caldarera CM
Biochem Biophys Res Commun; 1998 Feb; 243(3):821-6. PubMed ID: 9500985
[TBL] [Abstract][Full Text] [Related]
26. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases myocardial glucose uptake during reperfusion and induces late pre-conditioning: potential role of AMP-activated protein kinase.
Kristiansen SB; Solskov L; Jessen N; Løfgren B; Schmitz O; Nielsen-Kudsk JE; Nielsen TT; Bøtker HE; Lund S
Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):10-6. PubMed ID: 19486332
[TBL] [Abstract][Full Text] [Related]
27. LPS inhibits caspase 3-dependent apoptosis in RAW264.7 macrophages induced by the AMPK activator AICAR.
Russe OQ; Möser CV; Kynast KL; King TS; Olbrich K; Grösch S; Geisslinger G; Niederberger E
Biochem Biophys Res Commun; 2014 May; 447(3):520-5. PubMed ID: 24732361
[TBL] [Abstract][Full Text] [Related]
28. AICAR inhibits PPARγ during monocyte differentiation to attenuate inflammatory responses to atherogenic lipids.
Namgaladze D; Kemmerer M; von Knethen A; Brüne B
Cardiovasc Res; 2013 Jun; 98(3):479-87. PubMed ID: 23531513
[TBL] [Abstract][Full Text] [Related]
29. The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN).
Gao J; Xiong R; Xiong D; Zhao W; Zhang S; Yin T; Zhang X; Jiang G; Yin Z
Med Sci Monit; 2018 Nov; 24():8533-8543. PubMed ID: 30474622
[TBL] [Abstract][Full Text] [Related]
30. 5'-AMP-activated protein kinase (AMPK) regulates progesterone receptor transcriptional activity in breast cancer cells.
Wu L; Huang XJ; Yang CH; Deng SS; Qian M; Zang Y; Li J
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):172-7. PubMed ID: 22093824
[TBL] [Abstract][Full Text] [Related]
31. Regulation of visceral and subcutaneous adipocyte lipolysis by acute AICAR-induced AMPK activation.
Anthony NM; Gaidhu MP; Ceddia RB
Obesity (Silver Spring); 2009 Jul; 17(7):1312-7. PubMed ID: 19214174
[TBL] [Abstract][Full Text] [Related]
32. Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion.
Bradley EA; Eringa EC; Stehouwer CD; Korstjens I; van Nieuw Amerongen GP; Musters R; Sipkema P; Clark MG; Rattigan S
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1137-42. PubMed ID: 20224051
[TBL] [Abstract][Full Text] [Related]
33. AMP-activated protein kinase regulates the assembly of epithelial tight junctions.
Zhang L; Li J; Young LH; Caplan MJ
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17272-7. PubMed ID: 17088526
[TBL] [Abstract][Full Text] [Related]
34. 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages.
Jhun BS; Jin Q; Oh YT; Kim SS; Kong Y; Cho YH; Ha J; Baik HH; Kang I
Biochem Biophys Res Commun; 2004 May; 318(2):372-80. PubMed ID: 15120611
[TBL] [Abstract][Full Text] [Related]
35. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY
Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340
[TBL] [Abstract][Full Text] [Related]
36. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?
Corton JM; Gillespie JG; Hawley SA; Hardie DG
Eur J Biochem; 1995 Apr; 229(2):558-65. PubMed ID: 7744080
[TBL] [Abstract][Full Text] [Related]
37. 5-aminoimidazole-4-carboxamide ribonucleoside and AMP-activated protein kinase inhibit signalling through NF-κB.
Katerelos M; Mudge SJ; Stapleton D; Auwardt RB; Fraser SA; Chen CG; Kemp BE; Power DA
Immunol Cell Biol; 2010 Oct; 88(7):754-60. PubMed ID: 20404837
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
[TBL] [Abstract][Full Text] [Related]
39. AMPK signaling: a targetable tumor suppressor pathway?
Schneider A; Gartenhaus RB
Cancer Biol Ther; 2010 Dec; 10(11):1178-81. PubMed ID: 21057216
[No Abstract] [Full Text] [Related]
40. AMP-Activated Kinase (AMPK) Activation by AICAR in Human White Adipocytes Derived from Pericardial White Adipose Tissue Stem Cells Induces a Partial Beige-Like Phenotype.
Abdul-Rahman O; Kristóf E; Doan-Xuan QM; Vida A; Nagy L; Horváth A; Simon J; Maros T; Szentkirályi I; Palotás L; Debreceni T; Csizmadia P; Szerafin T; Fodor T; Szántó M; Tóth A; Kiss B; Bacsó Z; Bai P
PLoS One; 2016; 11(6):e0157644. PubMed ID: 27322180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
